{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:00:07Z","timestamp":1776186007261,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical therapy research in the specialist health services","award":["2017204"],"award-info":[{"award-number":["2017204"]}]},{"name":"Clinical therapy research in the specialist health services","award":["2017204"],"award-info":[{"award-number":["2017204"]}]},{"name":"Clinical therapy research in the specialist health services","award":["2017204"],"award-info":[{"award-number":["2017204"]}]},{"DOI":"10.13039\/100016190","name":"Trond Mohn stiftelse","doi-asserted-by":"publisher","award":["BFS2019TMT01"],"award-info":[{"award-number":["BFS2019TMT01"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016190","name":"Trond Mohn stiftelse","doi-asserted-by":"publisher","award":["BFS2019TMT01"],"award-info":[{"award-number":["BFS2019TMT01"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016190","name":"Trond Mohn stiftelse","doi-asserted-by":"publisher","award":["BFS2019TMT01"],"award-info":[{"award-number":["BFS2019TMT01"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Few studies have examined the use of concentrated and intensified cognitive behaviour therapy for treating social anxiety disorder (SAD). The aim of this study was to examine the feasibility of the Bergen 4-Day Treatment (B4DT) for treating SAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study adopted an open trial design without a control group. Thirty consecutively referred patients who were diagnosed with SAD were treated and assessed at pre-treatment, at post-treatment, and at the 3-month follow-up. The Liebowitz Social Anxiety Scale was used to assess symptoms of SAD; the Generalized Anxiety Disorder-7 scale was used to assess anxiety symptoms; and the Patient Health Questionnaire-9 was used to assess symptoms of anxiety and depression. The Client Satisfaction Questionnaire-8 was administered posttreatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, patients reported a high level of satisfaction with the B4DT. Large effect sizes were observed for symptoms of SAD (<jats:italic>d<\/jats:italic>\u2009=\u20091.94\u20132.66) and for the secondary outcomes, i.e., generalized anxiety (<jats:italic>d<\/jats:italic>\u2009=\u20090.86\u20130.99) and depression (<jats:italic>d<\/jats:italic>\u2009=\u20090.62\u20130.83). The remission rate was 55.2% at follow-up, while the treatment response rate was 89.7%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The B4DT is a promising treatment approach for patients with SAD. In the future, controlled trials should be performed to compare the efficacy of this treatment approach with standard outpatient treatment. Practical consequences, policy implications, and suggestions for future research are discussed herein.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-024-05607-4","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T06:02:40Z","timestamp":1708495360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Bergen 4-day treatment for social anxiety disorder: a pilot study"],"prefix":"10.1186","volume":"24","author":[{"given":"Bjarne","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorstein Olsen","family":"Eide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Aaslie","family":"Reir\u00e5skag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian August","family":"Tjelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stian","family":"Solem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"5607_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"5607_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","volume":"21","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169\u201384.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"3","key":"5607_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.janxdis.2012.01.003","volume":"26","author":"IM Aderka","year":"2012","unstructured":"Aderka IM, Hofmann SG, Nickerson A, Hermesh H, Gilboa-Schechtman E, Marom S. Functional impairment in social anxiety disorder. J Anxiety Disord. 2012;26(3):393\u2013400.","journal-title":"J Anxiety Disord"},{"key":"5607_CR4","doi-asserted-by":"publisher","first-page":"212573","DOI":"10.7573\/dic.212573","volume":"8","author":"A Koyuncu","year":"2019","unstructured":"Koyuncu A, \u0130nce E, Ertekin E, T\u00fckel R. Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges. Drugs Context. 2019;8:212573.","journal-title":"Drugs Context"},{"issue":"10","key":"5607_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/00048670903179111","volume":"43","author":"LA Lampe","year":"2009","unstructured":"Lampe LA. Social anxiety disorder: recent developments in psychological approaches to conceptualization and treatment. Australian New Z J Psychiatry. 2009;43(10):887\u201398.","journal-title":"Australian New Z J Psychiatry"},{"issue":"7","key":"5607_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.janxdis.2013.08.002","volume":"27","author":"C Steinert","year":"2013","unstructured":"Steinert C, Hofmann M, Leichsenring F, Kruse J. What do we know today about the prospective long-term course of social anxiety disorder? A systematic literature review. J Anxiety Disord. 2013;27(7):692\u2013702.","journal-title":"J Anxiety Disord"},{"key":"5607_CR7","doi-asserted-by":"publisher","first-page":"102407","DOI":"10.1016\/j.janxdis.2021.102407","volume":"81","author":"HC Levy","year":"2021","unstructured":"Levy HC, O\u2019Bryan EM, Tolin DF. A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders. J Anxiety Disord. 2021;81:102407.","journal-title":"J Anxiety Disord"},{"key":"5607_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.janxdis.2016.09.003","volume":"43","author":"P Cuijpers","year":"2016","unstructured":"Cuijpers P, Gentili C, Banos RM, Garcia-Campayo J, Botella C, Cristea IA. Relative effects of cognitive and behavioral therapies on generalized anxiety disorder, social anxiety disorder and panic disorder: a meta-analysis. J Anxiety Disord. 2016;43:79\u201389.","journal-title":"J Anxiety Disord"},{"issue":"5","key":"5607_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S2215-0366(14)70329-3","volume":"1","author":"E Mayo-Wilson","year":"2014","unstructured":"Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S. Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(5):368\u201376.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"5607_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1037\/cps0000144","volume":"30","author":"L-G \u00d6st","year":"2023","unstructured":"\u00d6st L-G, Enebrink P, Finnes A, Ghaderi A, Havnen A, Kvale G, et al. Cognitive behavior therapy for adult anxiety disorders in routine clinical care: a systematic review and meta-analysis. Clin Psychol Sci Pract. 2023;30(3):272\u201390.","journal-title":"Clin Psychol Sci Pract"},{"key":"5607_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpr.2018.03.002","volume":"61","author":"KS Springer","year":"2018","unstructured":"Springer KS, Levy HC, Tolin DF. Remission in CBT for adult anxiety disorders: a meta-analysis. Clin Psychol Rev. 2018;61:1\u20138.","journal-title":"Clin Psychol Rev"},{"key":"5607_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brat.2017.07.008","volume":"97","author":"LG \u00d6st","year":"2017","unstructured":"\u00d6st LG, Ollendick TH. Brief Intensive and concentrated cognitive behavioral treatments for anxiety disorders in children: a systematic review and Meta-analysis. Behav Res Ther. 2017;97:134\u201345.","journal-title":"Behav Res Ther"},{"key":"5607_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100267","volume":"6","author":"KCP Remmerswaal","year":"2021","unstructured":"Remmerswaal KCP, Lans L, Seldenrijk A, Hoogendoorn AW, van Balkom AJLM, Batelaan NM. Effectiveness and feasibility of intensive versus regular cognitive behaviour therapy in patients with anxiety and obsessive-compulsive disorders: a meta-analysis. J Affect Disorders Rep. 2021;6: 100267.","journal-title":"J Affect Disorders Rep"},{"issue":"11","key":"5607_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/da.23204","volume":"38","author":"A Pittig","year":"2021","unstructured":"Pittig A, Heinig I, Goerigk S, Thiel F, Hummel K, Scholl L, et al. Efficacy of temporally intensified exposure for anxiety disorders: a multicenter randomized clinical trial. Depress Anxiety. 2021;38(11):1169\u201381.","journal-title":"Depress Anxiety"},{"key":"5607_CR15","doi-asserted-by":"crossref","unstructured":"Heinig I, Knappe S, Hoyer J, Wittchen HU, Richter J, Arolt V, Deckert J, Domschke K, Hamm A, Kircher T, Lueken U, Margraf J, Neudeck P, Rief W, Straube B, Str\u00f6hle A, Pauli P, Pittig A. Effective-and Tolerable: Acceptance and Side Effects of Intensified Exposure for Anxiety Disorders. Behav Ther. 2023;54(3):427\u201343.","DOI":"10.1016\/j.beth.2022.11.001"},{"issue":"5","key":"5607_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.janxdis.2005.07.005","volume":"20","author":"E M\u00f6rtberg","year":"2006","unstructured":"M\u00f6rtberg E, Karlsson A, Fyring C, Sundin O. Intensive cognitive-behavioral group treatment (CBGT) of social phobia: a randomized controlled study. J Anxiety Disord. 2006;20(5):646\u201360.","journal-title":"J Anxiety Disord"},{"issue":"2","key":"5607_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1600-0447.2006.00839.x","volume":"115","author":"E M\u00f6rtberg","year":"2007","unstructured":"M\u00f6rtberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand. 2007;115(2):142\u201354.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"5607_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.janxdis.2011.06.007","volume":"25","author":"E M\u00f6rtberg","year":"2011","unstructured":"M\u00f6rtberg E, Clark DM, Bejerot S. Intensive group cognitive therapy and individual cognitive therapy for social phobia: sustained improvement at 5-year follow-up. J Anxiety Disord. 2011;25(8):994\u20131000.","journal-title":"J Anxiety Disord"},{"key":"5607_CR19","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","volume":"10","author":"G Launes","year":"2019","unstructured":"Launes G, Hagen K, Sunde T, \u00d6st LG, Klovning I, Laukvik IL, et al. A randomized controlled trial of concentrated ERP, Self-help and waiting list for obsessive- compulsive disorder: the Bergen 4-Day treatment. Front Psychol. 2019;10:2500.","journal-title":"Front Psychol"},{"issue":"8","key":"5607_CR20","doi-asserted-by":"publisher","first-page":"e2013249","DOI":"10.1001\/jamanetworkopen.2020.13249","volume":"3","author":"G Kvale","year":"2020","unstructured":"Kvale G, Hansen B, Hagen K, Abramowitz JS, B\u00f8rtveit T, Craske MG, et al. Effect of D-Cycloserine on the effect of concentrated exposure and response prevention in difficult-to-treat obsessive-compulsive disorder: a randomized clinical trial. JAMA Netw Open. 2020;3(8):e2013249.","journal-title":"JAMA Netw Open"},{"key":"5607_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fpsyg.2019.01069","volume":"10","author":"G Launes","year":"2019","unstructured":"Launes G, Laukvik IL, Sunde T, Klovning I, Hagen K, Solem S, et al. The Bergen 4-Day treatment for obsessive-compulsive disorder: does it work in a new clinical setting? Front Psychol. 2019;10:1069.","journal-title":"Front Psychol"},{"key":"5607_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fpsyg.2018.00639","volume":"9","author":"B Hansen","year":"2018","unstructured":"Hansen B, Hagen K, \u00d6st LG, Solem S, Kvale G. The Bergen 4-Day OCD treatment delivered in a group setting: 12-Month Follow-Up. Front Psychol. 2018;9:639.","journal-title":"Front Psychol"},{"issue":"2","key":"5607_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/16506073.2018.1478447","volume":"48","author":"B Hansen","year":"2019","unstructured":"Hansen B, Kvale G, Hagen K, Havnen A, \u00d6st LG. The Bergen 4-Day treatment for OCD: four years Follow-Up of concentrated ERP in a clinical Mental Health setting. Cogn Behav Ther. 2019;48(2):89\u2013105.","journal-title":"Cogn Behav Ther"},{"issue":"1","key":"5607_CR24","first-page":"33","volume":"16","author":"SD Dav\u00ed\u00f0sd\u00f3ttir","year":"2019","unstructured":"Dav\u00ed\u00f0sd\u00f3ttir SD, Sigurj\u00f3nsd\u00f3ttir \u00d3, Ludvigsd\u00f3ttir SJ, Hansen B, Laukvik IL, Hagen K, et al. Implementation of the Bergen 4-Day treatment for obsessive compulsive disorder in Iceland. Clin Neuropsychiatry. 2019;16(1):33\u20138.","journal-title":"Clin Neuropsychiatry"},{"issue":"1","key":"5607_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12888-018-1887-4","volume":"18","author":"G Kvale","year":"2018","unstructured":"Kvale G, Hansen B, Bjorgvinsson T, Bortveit T, Hagen K, Haseth S, et al. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-Day treatment. BMC Psychiatry. 2018;18(1):323.","journal-title":"BMC Psychiatry"},{"key":"5607_CR26","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fpsyg.2018.01044","volume":"9","author":"B Hansen","year":"2018","unstructured":"Hansen B, Kvale G, Hagen K, Hjelle KM, Solem S, B\u00f8 B, \u00d6st LG. The Bergen 4-Day treatment for panic disorder: a pilot study. Front Psychol. 2018;9:1044.","journal-title":"Front Psychol"},{"issue":"1","key":"5607_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12888-023-04812-x","volume":"23","author":"TO Eide","year":"2023","unstructured":"Eide TO, Hjelle KM, S\u00e6tre IU, Solem S, Olsen T, Sk\u00f6ld RO, et al. The Bergen 4-day treatment for panic disorder: implementation in a rural clinical setting. BMC Psychiatry. 2023;23(1):305.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"5607_CR28","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s12888-022-04380-6","volume":"22","author":"HM Iversen","year":"2022","unstructured":"Iversen HM, Eide TO, Harvold M, Solem S, Kvale G, Hansen B, Hagen K. The Bergen 4-day treatment for panic disorder: replication and implementation in a new clinic. BMC Psychiatry. 2022;22(1):728.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"5607_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12888-023-05062-7","volume":"23","author":"KM Hjelle","year":"2023","unstructured":"Hjelle KM, Eide TO, Thorsen AL, Kvale G, Hagen K, Snorrason I, et al. The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities. BMC Psychiatry. 2023;23(1):570.","journal-title":"BMC Psychiatry"},{"key":"5607_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000414022","volume":"22","author":"MR Liebowitz","year":"1987","unstructured":"Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141\u201373.","journal-title":"Mod Probl Pharmacopsychiatry"},{"issue":"6","key":"5607_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0887-6185(02)00134-2","volume":"16","author":"DS Mennin","year":"2002","unstructured":"Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social anxiety scale. J Anxiety Disord. 2002;16(6):661\u201373.","journal-title":"J Anxiety Disord"},{"issue":"1","key":"5607_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1017\/S0033291798007879","volume":"29","author":"RG Heimberg","year":"1999","unstructured":"Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR. Psychometric properties of the liebowitz social anxiety scale. Psychol Med. 1999;29(1):199\u2013212.","journal-title":"Psychol Med"},{"issue":"10","key":"5607_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"9","key":"5607_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"5607_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"5607_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","volume":"2","author":"DL Larsen","year":"1979","unstructured":"Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client\/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197\u2013207.","journal-title":"Eval Program Plann"},{"issue":"Suppl 20","key":"5607_CR37","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333 quiz 4\u201357.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"5607_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.eurpsy.2009.02.004","volume":"25","author":"J Mordal","year":"2010","unstructured":"Mordal J, Gundersen \u00d8, Bramness JG. Norwegian version of the mini-international neuropsychiatric interview: feasibility, acceptability and test-retest reliability in an acute psychiatric ward. Eur Psychiatry. 2010;25(3):172\u20137.","journal-title":"Eur Psychiatry"},{"key":"5607_CR39","doi-asserted-by":"publisher","DOI":"10.1201\/9781439821862","volume-title":"Analysis of incomplete Multivariate Data","author":"JL Schafer","year":"1997","unstructured":"Schafer JL. Analysis of incomplete Multivariate Data. 1st ed. New York: Chapman and Hall\/CRC; 1997.","edition":"1"},{"issue":"2","key":"5607_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4088\/JCP.v66n0213","volume":"66","author":"MR Liebowitz","year":"2005","unstructured":"Liebowitz MR, Mangano RM, Bradwejn J, Asnis G. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry. 2005;66(2):238\u201347.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"5607_CR41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1176\/appi.ajp.2013.12081125","volume":"170","author":"F Leichsenring","year":"2013","unstructured":"Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, et al. Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial. Am J Psychiatry. 2013;170(7):759\u201367.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"5607_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cpp.2179","volume":"25","author":"M von Glischinski","year":"2018","unstructured":"von Glischinski M, Willutzki U, Stangier U, Hiller W, Hoyer J, Leibing E, et al. Liebowitz Social Anxiety Scale (LSAS): optimal cut points for remission and response in a German sample. Clin Psychol Psychother. 2018;25(3):465\u201373.","journal-title":"Clin Psychol Psychother"},{"issue":"9","key":"5607_CR43","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.4088\/JCP.v67n0914","volume":"67","author":"B Bandelow","year":"2006","unstructured":"Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J Clin Psychiatry. 2006;67(9):1428\u201334.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"5607_CR44","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1037\/a0015813","volume":"77","author":"T Aune","year":"2009","unstructured":"Aune T, Stiles TC. Universal-based prevention of syndromal and subsyndromal social anxiety: a randomized controlled study. J Consult Clin Psychol. 2009;77(5):867\u201379.","journal-title":"J Consult Clin Psychol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05607-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T09:07:08Z","timestamp":1708506428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05607-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5607"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05607-4","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"17 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed by the regional committee of ethics for human research (REK S\u00f8r-\u00d8st 2023\/ 603288). Informed written consent was obtained from all subjects. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}